Front-Line Paclitaxel/Cisplatin-Based Chemotherapy in Brain Metastases from Non-Small-Cell Lung Cancer

Publisher： Karger

E-ISSN： 1423-0232|64|1|28-35

ISSN： 0030-2414

Source： Oncology, Vol.64, Iss.1, 2002-12, pp. : 28-35

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Chemotherapy of Cisplatin, Ifosfamide, and Irinotecan with rhG-CSF Support in Patients with Brain Metastases from Non-Small Cell Lung Cancer

By  

Oncology, Vol. 59, Iss. 4, 2000-11 ,pp. : 291-295

Karger

Access to resources Recommend Favorite

Predicting Chemotherapy Response to Paclitaxel-Based Therapy in Advanced Non-Small-Cell Lung Cancer with P-Glycoprotein Expression

By  

Respiration, Vol. 70, Iss. 1, 2003-02 ,pp. : 32-35

Karger

Access to resources Recommend Favorite

Predicting Chemotherapy Response to Paclitaxel-Based Therapy in Advanced Non-Small-Cell Lung Cancer (Stage IIIb or IV) with a Higher T Stage (> T2)

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 173-179

Karger

Access to resources Recommend Favorite

Whole Brain Radiotherapy-Based Combined Modality Treatment of Brain Metastases from Non-Small Cell Lung Cancer: A Retrospective Analysis of Prognostic Factors

By  

Oncology Research and Treatment, Vol. 38, Iss. 1-2, 2015-01 ,pp. : 35-40

Karger

Access to resources Recommend Favorite

Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel

By  

Oncology, Vol. 64, Iss. 4, 2003-05 ,pp. : 399-406

Karger

Access to resources Recommend Favorite